mechanism shared by glucocorticoids and IL-10 macrophages: an anti-inflammatory and immunosuppressive Synthesis of glucocorticoid-induced leucine zipper (GILZ) by

doi:10.1182/blood-2002-02-0538Prepublished online September 12, 2002;2003 101: 729-738€€€€Peuchmaur, Carlo Riccardi and Dominique EmilieBouchet-Delbos, Marie-Christine Maillot, Alain Portier, Jacques Couderc, Pierre Galanaud, Michel Dominique Berrebi, Stefano Bruscoli, Nicolas Cohen, Arnaud Foussat, Graziella Migliorati, Laurence€

[1]  D. Joshua,et al.  Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10. , 2001, Blood.

[2]  R. Darnell,et al.  Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells , 2001, Nature Immunology.

[3]  W. Heath,et al.  Immunity or tolerance? That is the question for dendritic cells , 2001, Nature Immunology.

[4]  Michel C. Nussenzweig,et al.  Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo , 2001, The Journal of experimental medicine.

[5]  S. Akira,et al.  Toll-like receptors control activation of adaptive immune responses , 2001, Nature Immunology.

[6]  J. Ashwell,et al.  Inhibition of AP-1 by the Glucocorticoid-inducible Protein GILZ* , 2001, The Journal of Biological Chemistry.

[7]  C. Riccardi,et al.  Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB. , 2001, Blood.

[8]  P. Rutgeerts,et al.  B7 Interactions with CD28 and CTLA-4 Control Tolerance or Induction of Mucosal Inflammation in Chronic Experimental Colitis1 , 2001, The Journal of Immunology.

[9]  S. Akira,et al.  Toll-like receptors: critical proteins linking innate and acquired immunity , 2001, Nature Immunology.

[10]  J. Todd.  Human genetics: Tackling common disease , 2001, Nature.

[11]  H. Wagner,et al.  Toll meets bacterial CpG-DNA. , 2001, Immunity.

[12]  D. Golenbock,et al.  Extolling the diversity of bacterial endotoxins , 2001, Nature Immunology.

[13]  C. Riccardi,et al.  Cloning, chromosomal assignment and tissue distribution of human GILZ, a glucocorticoid hormone-induced gene , 2001, Cell Death and Differentiation.

[14]  Yong‐jun Liu,et al.  Anti–Interleukin 10 Receptor Monoclonal Antibody Is an Adjuvant for T Helper Cell Type 1 Responses to Soluble Antigen Only in the Presence of Lipopolysaccharide , 2000, The Journal of experimental medicine.

[15]  A. Mantovani,et al.  Macrophage‐derived chemokine (MDC) , 2000, Journal of leukocyte biology.

[16]  A. Aderem,et al.  Toll-like receptors in the induction of the innate immune response , 2000, Nature.

[17]  G. Ghandour,et al.  B‐lymphocyte quiescence, tolerance and activation as viewed by global gene expression profiling on microarrays , 2000, Immunological reviews.

[18]  J. Steer,et al.  Glucocorticoids Suppress Tumor Necrosis Factor-α Expression by Human Monocytic THP-1 Cells by Suppressing Transactivation through Adjacent NF-κB and c-Jun-Activating Transcription Factor-2 Binding Sites in the Promoter* , 2000, The Journal of Biological Chemistry.

[19]  P. Allavena,et al.  Differential Expression and Regulation of Toll-Like Receptors (TLR) in Human Leukocytes: Selective Expression of TLR3 in Dendritic Cells1 , 2000, The Journal of Immunology.

[20]  Richard A. Flavell,et al.  Inhibition of NF-κB Activity and Enhancement of Apoptosis by the Neuropeptide Calcitonin Gene-related Peptide* , 2000, The Journal of Biological Chemistry.

[21]  J. Hiscott,et al.  Regulation of RANTES Chemokine Gene Expression Requires Cooperativity Between NF-κB and IFN-Regulatory Factor Transcription Factors1 , 2000, The Journal of Immunology.

[22]  Barbara Bottazzi,et al.  Autocrine Production of IL-10 Mediates Defective IL-12 Production and NF-κB Activation in Tumor-Associated Macrophages1 , 2000, The Journal of Immunology.

[23]  A. Foussat,et al.  Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human , 2000, European journal of immunology.

[24]  D. Green,et al.  T cells are just dying to accept grafts , 1999, Nature Medicine.

[25]  E. Allenspach,et al.  Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granulomatous inflammation. , 1999, Journal of immunology.

[26]  A. Enk,et al.  Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. , 1999, Blood.

[27]  M. Roncarolo,et al.  A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. , 1999, Journal of immunology.

[28]  R. Schwartz,et al.  Molecular regulation of interleukin‐2 expression by CD28 co‐stimulation and anergy , 1998, Immunological reviews.

[29]  H. Herschman,et al.  The murine neutrophil‐chemoattractant chemokines LIX, KC, and MIP‐2 have distinct induction kinetics, tissue distributions, and tissue‐specific sensitivities to glucocorticoid regulation in endotoxemia , 1998, Journal of leukocyte biology.

[30]  S. Manna,et al.  IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis. , 1998, Journal of immunology.

[31]  M. Girndt,et al.  Glucocorticoids inhibit activation-dependent expression of costimulatory molecule B7-1 in human monocytes. , 1998, Transplantation.

[32]  J. Reul,et al.  Induction of cytokine receptors by glucocorticoids: functional and pathological significance. , 1998, Trends in pharmacological sciences.

[33]  M. Karin.  New Twists in Gene Regulation by Glucocorticoid Receptor: Is DNA Binding Dispensable? , 1998, Cell.

[34]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[35]  J. Banchereau,et al.  An update on interleukin-4 and its receptor. , 1997, European cytokine network.

[36]  T. Billiar,et al.  Dexamethasone suppresses iNOS gene expression by upregulating I-κBα and inhibiting NF-κB. , 1997, American journal of physiology. Gastrointestinal and liver physiology.

[37]  C. Riccardi,et al.  A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. , 1997, Immunity.

[38]  R. Voll,et al.  Immunosuppressive effects of apoptotic cells , 1997, Nature.

[39]  M. Goppelt‐Struebe,et al.  Differential regulation of cyclo‐oxygenase‐2 and 5‐lipoxygenase‐activating protein (FLAP) expression by glucocorticoids in monocytic cells , 1997, British journal of pharmacology.

[40]  C. Riccardi,et al.  CD2 rescues T cells from T-cell receptor/CD3 apoptosis: a role for the Fas/Fas-L system. , 1997, Blood.

[41]  M. Karin,et al.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.

[42]  D. Cockayne,et al.  IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production. , 1997, Journal of immunology.

[43]  M. Perretti,et al.  Subacute treatment of rats with dexamethasone reduces ICAM-1 levels on circulating monocytes. , 1997, Biochemical and biophysical research communications.

[44]  M. Humbert,et al.  Contrasting effects of IL-4, IL-10 and corticosteroids on RANTES production by human monocytes. , 1996, International immunology.

[45]  T. Idziorek,et al.  T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)- mediated apoptosis of CD4+ T cells from human immunodeficiency virus- infected persons , 1995, The Journal of experimental medicine.

[46]  K. Chung,et al.  Corticosteroid inhibition of macrophage inflammatory protein-1 alpha in human monocytes and alveolar macrophages. , 1995, The American journal of physiology.

[47]  Santa Jeremy Ono,et al.  Modulation of MHC class II expression in human cells by dexamethasone. , 1995, Cellular immunology.

[48]  A. Siccardi,et al.  IL-13 down-regulates CD14 expression and TNF-alpha secretion in normal human monocytes. , 1995, Journal of immunology.

[49]  T. Schall,et al.  Induction of chemokine gene expression by major histocompatibility complex class II ligands in human fibroblast-like synoviocytes. Differential regulation by interleukin-4 and dexamethasone. , 1994, The Journal of biological chemistry.

[50]  T. Schall,et al.  Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells [published erratum appears in J Exp Med 1994 Aug 1;180(2):775] , 1994, Journal of Experimental Medicine.

[51]  J. Johnson,et al.  12-O-tetradecanoylphorbol-13-acetate- and tumor necrosis factor alpha-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. Functional analysis of the human intercellular adhesion molecular-1 promoter. , 1994, The Journal of biological chemistry.

[52]  P. Casellas,et al.  lnterleukin-13 is a new human lymphokine regulating inflammatory and immune responses , 1993, Nature.

[53]  K. Matsushima,et al.  Dexamethasone inhibits the induction of monocyte chemotactic-activating factor production by IL-1 or tumor necrosis factor. , 1991, Journal of immunology.

[54]  S. Ghosh,et al.  Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. , 2001, The Journal of clinical investigation.

[55]  C. Bona,et al.  Interleukin-10 as a key regulator of inflammation and stress responses , 2000 .

[56]  J. D. de Vries,et al.  Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. , 1994, Immunology today.